Literature DB >> 8308270

Enhanced IgG production in eRDF media with and without serum. A comparative study.

F Chua1, S K Oh, M Yap, W K Teo.   

Abstract

The performance of three basal media RPMI, DMEM/F12 (DF) and eRDF (enhanced RDF, RPMI:DMEM:F12 in 2:1:1) were evaluated in cultures with and without serum with respect to cell proliferation, metabolism and monoclonal antibody (Mab) productivity. Based on the ease of adaptation, growth rate, maximum cell density and Mab production, the media were ranked as follows: eRDF > DF > RPMI. This was true for serum-free (SF) and serum supplemented (SS) media in static and shaker cultures. Growth performances in static and shaker cultures were consistently 20-50% lower in all three SF media compared to the corresponding SS conditions. Antibody titres in DF/SF and RPMI/SF cultures, irrespective of the culture condition, were generally similar or slightly lower than their SS counterparts. However, eRDF/SF medium yielded a much higher Mab titre (193 mg l-1) compared to eRDF/SS medium (145 mg l-1). This was also six times higher than the lowest titre of 30 mg l-1 in RPMI/SF medium. Hybridomas in eRDF/SF were further adapted to media without bovine serum albumin (eRDF/SF-BSA). Maximum cell densities in these cultures improved with scale up, from 1.1 x 10(6) ml-1 in static, to 1.9 x 10(6) ml-1 in shaker flasks, to 2.5 x 10(6) ml-1 in bioreactors. However, Ig levels remained between 100-130 mg l-1 which were much lower than in eRDF/SF medium. Thus BSA appears to be necessary for Ig production. The manufacturing cost (excluding purification) of Ig using eRDF was calculated to be between 17-50% of the price of the other two media and therefore this is regarded as the best medium for Ig production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8308270     DOI: 10.1016/0022-1759(94)90080-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  The role of vitamins and amino acids on hybridoma growth and monoclonal antibody production.

Authors:  P Ducommun; P A Ruffieux; U von Stockar; I Marison
Journal:  Cytotechnology       Date:  2001-10       Impact factor: 2.058

2.  Facile development of medium optimization for antibody production: implementation in spinner flask and hollow fiber reactor.

Authors:  Chi-Hsien Liu; Yi-Xin Liu; Wei-Chi Wu
Journal:  Cytotechnology       Date:  2018-10-03       Impact factor: 2.058

3.  Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis.

Authors:  Lubos Comor; Saskia Dolinska; Katarina Bhide; Lucia Pulzova; Irene Jiménez-Munguía; Elena Bencurova; Zuzana Flachbartova; Lenka Potocnakova; Evelina Kanova; Mangesh Bhide
Journal:  Microb Cell Fact       Date:  2017-01-23       Impact factor: 5.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.